Science Explorer Interactive view Map
Company · Mannheim · Germany

Vaximm (Germany)

Research works
5
▲ 136% vs 2013–17
Citations
61
13.2 per fractional work
Top-10% rate
10.0%
record average 16.5%
Open access
26%
world 28%

Not ranked overall: Vaximm (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Vaximm (Germany) publish most on?

By volume: Cancer Research and Treatments, Virus-based gene therapy research, Pancreatic and Hepatic Oncology Research and CAR-T cell therapy research.

  1. 1 Cancer Research and Treatments Biotechnology 2 works
  2. 2 Virus-based gene therapy research Genetics 1 works
  3. 3 Pancreatic and Hepatic Oncology Research Oncology 1 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Glioma Diagnosis and Treatment Genetics 0 works
  6. 6 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  7. 7 Immunotherapy and Immune Responses Immunology 0 works
  8. 8 Hepatitis B Virus Studies Epidemiology 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 Insect and Pesticide Research Insect Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.1%not open73.9%

World: 28% of research is openly available.

with international co-authors48.2%domestic only51.8%

World: 19% is written across borders.

How has Vaximm (Germany)'s research output changed?

Output in 2018–2022 was 136% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mannheim

All research institutions in Mannheim

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.